Economic Evaluation of Ready-to-Dilute Thiotepa (Tepylute®): Institutional Cost Offsets and Time Savings Compared to Lyophilized Thiotepa in a United States Hospital Pharmacy

Orlaith Ryan, Maurice Clancy, Alanna MacDonald, Laura Pastor, Megan Bourque

Open source

DOI
10.2147/ceor.s559251
Published
2026-01
Container
ClinicoEconomics and Outcomes Research
Publisher
Informa UK Limited
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2147/ceor.s559251,
  title = {Economic Evaluation of Ready-to-Dilute Thiotepa (Tepylute®): Institutional Cost Offsets and Time Savings Compared to Lyophilized Thiotepa in a United States Hospital Pharmacy},
  author = {Orlaith Ryan and Maurice Clancy and Alanna MacDonald and Laura Pastor and Megan Bourque},
  year = {2026},
  journal = {ClinicoEconomics and Outcomes Research},
  doi = {10.2147/ceor.s559251},
  url = {https://doi.org/10.2147/ceor.s559251}
}

RIS

TY  - JOUR
TI  - Economic Evaluation of Ready-to-Dilute Thiotepa (Tepylute®): Institutional Cost Offsets and Time Savings Compared to Lyophilized Thiotepa in a United States Hospital Pharmacy
AU  - Orlaith Ryan
AU  - Maurice Clancy
AU  - Alanna MacDonald
AU  - Laura Pastor
AU  - Megan Bourque
PY  - 2026
JO  - ClinicoEconomics and Outcomes Research
DO  - 10.2147/ceor.s559251
UR  - https://doi.org/10.2147/ceor.s559251
ER  - 

APA

Ryan, O., Clancy, M., MacDonald, A., Pastor, L., & Bourque, M. (2026). Economic Evaluation of Ready-to-Dilute Thiotepa (Tepylute®): Institutional Cost Offsets and Time Savings Compared to Lyophilized Thiotepa in a United States Hospital Pharmacy. ClinicoEconomics and Outcomes Research. https://doi.org/10.2147/ceor.s559251

Source records